Annual EBIT
-$22.49 M
-$3.41 M-17.87%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual earnings before interest & taxes is -$22.49 million, with the most recent change of -$3.41 million (-17.87%) on June 30, 2024.
- During the last 3 years, BNTC annual EBIT has fallen by -$8.61 million (-62.08%).
- BNTC annual EBIT is now -970.69% below its all-time high of $2.58 million, reached on June 30, 2019.
Performance
BNTC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.79 M
-$316.00 K-5.77%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly earnings before interest & taxes is -$5.79 million, with the most recent change of -$316.00 thousand (-5.77%) on September 30, 2024.
- Over the past year, BNTC quarterly EBIT has increased by +$1.00 million (+14.74%).
- BNTC quarterly EBIT is now -880.35% below its all-time high of $742.10 thousand, reached on September 30, 2016.
Performance
BNTC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.33 M
+$83.00 K+0.37%
September 30, 2024
Summary
- As of February 7, 2025, BNTC TTM earnings before interest & taxes is -$22.33 million, with the most recent change of +$83.00 thousand (+0.37%) on September 30, 2024.
- Over the past year, BNTC TTM EBIT has dropped by -$1.07 million (-5.04%).
- BNTC TTM EBIT is now -2740.63% below its all-time high of -$786.20 thousand, reached on March 31, 2015.
Performance
BNTC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BNTC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.9% | +14.7% | -5.0% |
| 3 y3 years | -62.1% | +14.7% | -5.0% |
| 5 y5 years | -970.7% | +14.7% | -5.0% |
BNTC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.1% | at low | -77.4% | +14.7% | -30.4% | +0.4% |
| 5 y | 5-year | -970.7% | at low | -174.3% | +14.7% | -581.5% | +0.4% |
| alltime | all time | -970.7% | at low | -880.4% | +14.7% | -2740.6% | +0.4% |
Benitec Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.79 M(+5.8%) | -$22.33 M(-0.4%) |
| Jun 2024 | -$22.49 M(+17.9%) | -$5.47 M(+28.1%) | -$22.42 M(+6.0%) |
| Mar 2024 | - | -$4.28 M(-37.1%) | -$21.15 M(-0.5%) |
| Dec 2023 | - | -$6.79 M(+15.6%) | -$21.26 M(+7.0%) |
| Sep 2023 | - | -$5.87 M(+39.7%) | -$19.87 M(+4.1%) |
| Jun 2023 | -$19.08 M(+5.0%) | -$4.21 M(-4.2%) | -$19.08 M(-4.3%) |
| Mar 2023 | - | -$4.39 M(-18.7%) | -$19.93 M(+6.0%) |
| Dec 2022 | - | -$5.40 M(+6.3%) | -$18.81 M(+3.2%) |
| Sep 2022 | - | -$5.08 M(+0.5%) | -$18.22 M(+0.2%) |
| Jun 2022 | -$18.18 M(+31.0%) | -$5.06 M(+54.9%) | -$18.18 M(+6.2%) |
| Mar 2022 | - | -$3.27 M(-32.1%) | -$17.12 M(-3.6%) |
| Dec 2021 | - | -$4.81 M(-4.6%) | -$17.76 M(+9.6%) |
| Sep 2021 | - | -$5.04 M(+26.0%) | -$16.20 M(+17.0%) |
| Jun 2021 | -$13.88 M(+67.6%) | -$4.00 M(+2.4%) | -$13.85 M(+8.8%) |
| Mar 2021 | - | -$3.91 M(+20.2%) | -$12.73 M(+16.4%) |
| Dec 2020 | - | -$3.25 M(+20.8%) | -$10.94 M(+11.6%) |
| Sep 2020 | - | -$2.69 M(-6.8%) | -$9.80 M(+18.4%) |
| Jun 2020 | -$8.28 M | -$2.89 M(+36.8%) | -$8.28 M(+53.6%) |
| Mar 2020 | - | -$2.11 M(0.0%) | -$5.39 M(+64.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$2.11 M(+81.0%) | -$3.28 M(+181.0%) |
| Sep 2019 | - | -$1.17 M(-48.8%) | -$1.17 M(-86.6%) |
| Jun 2019 | $2.58 M(-129.6%) | - | - |
| Jun 2018 | -$8.73 M(+100.4%) | -$2.28 M(+10.0%) | -$8.73 M(+2.1%) |
| Mar 2018 | - | -$2.07 M(-5.3%) | -$8.55 M(+30.7%) |
| Dec 2017 | - | -$2.18 M(-0.7%) | -$6.54 M(-10.4%) |
| Sep 2017 | - | -$2.20 M(+4.9%) | -$7.30 M(+67.5%) |
| Jun 2017 | -$4.36 M(-72.7%) | -$2.10 M(+3194.8%) | -$4.36 M(-18.8%) |
| Mar 2017 | - | -$63.60 K(-97.8%) | -$5.37 M(-26.8%) |
| Dec 2016 | - | -$2.94 M(-496.2%) | -$7.33 M(-20.5%) |
| Sep 2016 | - | $742.10 K(-123.9%) | -$9.22 M(-42.2%) |
| Jun 2016 | -$15.96 M(+99.4%) | -$3.10 M(+53.1%) | -$15.96 M(+2.1%) |
| Mar 2016 | - | -$2.03 M(-58.0%) | -$15.63 M(+8.6%) |
| Dec 2015 | - | -$4.83 M(-19.5%) | -$14.39 M(+50.5%) |
| Sep 2015 | - | -$6.00 M(+116.5%) | -$9.56 M(+168.7%) |
| Jun 2015 | -$8.01 M(-22.8%) | -$2.77 M(+252.4%) | -$3.56 M(+352.4%) |
| Mar 2015 | - | -$786.20 K | -$786.20 K |
| Jun 2014 | -$10.37 M(+53.9%) | - | - |
| Jun 2013 | -$6.74 M | - | - |
FAQ
- What is Benitec Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Benitec Biopharma?
- What is Benitec Biopharma annual EBIT year-on-year change?
- What is Benitec Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Benitec Biopharma?
- What is Benitec Biopharma quarterly EBIT year-on-year change?
- What is Benitec Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Benitec Biopharma?
- What is Benitec Biopharma TTM EBIT year-on-year change?
What is Benitec Biopharma annual earnings before interest & taxes?
The current annual EBIT of BNTC is -$22.49 M
What is the all time high annual EBIT for Benitec Biopharma?
Benitec Biopharma all-time high annual earnings before interest & taxes is $2.58 M
What is Benitec Biopharma annual EBIT year-on-year change?
Over the past year, BNTC annual earnings before interest & taxes has changed by -$3.41 M (-17.87%)
What is Benitec Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of BNTC is -$5.79 M
What is the all time high quarterly EBIT for Benitec Biopharma?
Benitec Biopharma all-time high quarterly earnings before interest & taxes is $742.10 K
What is Benitec Biopharma quarterly EBIT year-on-year change?
Over the past year, BNTC quarterly earnings before interest & taxes has changed by +$1.00 M (+14.74%)
What is Benitec Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of BNTC is -$22.33 M
What is the all time high TTM EBIT for Benitec Biopharma?
Benitec Biopharma all-time high TTM earnings before interest & taxes is -$786.20 K
What is Benitec Biopharma TTM EBIT year-on-year change?
Over the past year, BNTC TTM earnings before interest & taxes has changed by -$1.07 M (-5.04%)